Vicente Villanueva, Xiana Rodriguez-Osorio, Álvaro Juiz-Fernández, Debora Sayas, Kevin Hampel, Ascensión Castillo, Javier Montoya, Mercedes Garcés, Dulce Campos, Eduardo Rubio-Nazábal, Alejandro Fernández-Cabrera, Ariadna Gifreu, Estevo Santamarina, Guillermo Hernández Pérez, Mercé Falip, Beatriz Parejo-Carbonell, Irene García-Morales, Ana Belen Martínez, Margarita Massot, Montserrat Asensio, Juana Giménez, Virginia Guillén, Jesus Ruiz-Giménez, Beatriz Chavarria, Rodrigo Rocamora, Inés Escalza
PURPOSE: Urgent seizures are a medical emergency for which new therapies are still needed. This study evaluated the use of intravenous brivaracetam (IV-BRV) in an emergency setting in clinical practice. METHODS: BRIV-IV was a retrospective, multicenter, observational study. It included patients ≥18 years old who were diagnosed with urgent seizures (including status epilepticus (SE), acute repetitive seizures, and high-risk seizures) and who were treated with IV-BRV according to clinical practice in 14 hospital centers...
August 25, 2023: Epilepsy & Behavior: E&B